Clene Inc Stock price
Is Clene Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Clene Inc Stock Analysis
Analyst Opinions
11 Analysts have issued a Clene Inc forecast:
Analyst Opinions
11 Analysts have issued a Clene Inc forecast:
Don't miss a Thing! We will send you all news about Clene Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Clene Inc Stock News
Company Profile
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.
| Head office | United States |
| CEO | Mr. Etherington |
| Employees | 78 |
| Founded | 2013 |
| Website | clene.com |


